These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27033280)

  • 1. A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face.
    Kumar MH; Kumar MS; Kumar SH; Kumar KS
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
    Nitzschner H
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience in the treatment of progressive scleroderma with hyaluronidase].
    Janković D; Mladenović P; Arnerić S; Stanković K
    Srp Arh Celok Lek; 1975 Jun; 103(6):531-4. PubMed ID: 1209350
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison Of Efficacy Of Steroids Alone And Combination Of Steroids With Hyaluronidase On Mouth Opening In Oral Submucous Fibrosis Patients.
    Liaqat S; Ullah A; Waqas MA; Pervez N; Din SU; Ara N
    J Ayub Med Coll Abbottabad; 2022; 34(4):812-816. PubMed ID: 36566405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis.
    Hayakawa I; Sato S; Echigo T; Shirasaki F; Hasegawa M; Takehara K
    Clin Rheumatol; 2004 Aug; 23(4):345-7. PubMed ID: 15293097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dexamethasone pulse therapy in progressive systemic sclerosis.
    Pai BS; Srinivas CR; Sabitha L; Shenoi SD; Balachandran CN; Acharya S
    Int J Dermatol; 1995 Oct; 34(10):726-8. PubMed ID: 8537165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with hyaluronidase in dermatology].
    Wozniak KD; Braun W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of hyaluronidase in the treatment of chronic skin ulcers in diffuse generalized scleroderma.
    POPKIN RJ
    Angiology; 1952 Aug; 3(4):335-42. PubMed ID: 14952881
    [No Abstract]   [Full Text] [Related]  

  • 10. [Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients].
    Vincent C; Agard C; Barbarot S; N'Guyen JM; Planchon B; Durant C; Pistorius MA; Dreno B; Ponge T; Stalder JF; Mercier JM; Hamidou M
    Rev Med Interne; 2009 Jan; 30(1):5-11. PubMed ID: 18757116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase].
    Petter O; Bellmann H
    Hautarzt; 1971 Jan; 22(1):32-3. PubMed ID: 4251354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orofacial manifestations of systemic sclerosis: A study of 30 consecutive patients].
    Vincent C; Agard C; Barbarot S; N'guyen JM; Planchon B; Durant C; Pistorius MA; Dreno B; Ponge T; Stalder JF; Mercier JM; Hamidou M
    Rev Stomatol Chir Maxillofac; 2010 Jun; 111(3):128-34. PubMed ID: 20553704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of scleroderma with depolymerizing agents].
    Konopík J; Krs V
    Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
    [No Abstract]   [Full Text] [Related]  

  • 15. Brachial plexopathy associated with diffuse edematous scleroderma.
    Mouthon L; Halimi C; Dussaule Md JC; Cayre-Castel Md M; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orofacial manifestations of scleroderma. A literature review.
    Hadj Said M; Foletti JM; Graillon N; Guyot L; Chossegros C
    Rev Stomatol Chir Maxillofac Chir Orale; 2016 Nov; 117(5):322-326. PubMed ID: 27475503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis and calcinosis cutis: response to rituximab.
    Poormoghim H; Andalib E; Almasi AR; Hadibigi E
    J Clin Pharm Ther; 2016 Feb; 41(1):94-6. PubMed ID: 26667314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral submucous fibrosis--treatment with hyalase.
    Kakar PK; Puri RK; Venkatachalam VP
    J Laryngol Otol; 1985 Jan; 99(1):57-9. PubMed ID: 3968475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited cutaneous systemic sclerosis: report of one case.
    Lin MC; Fu LS; Huang KY; Tsen CF; Liou JM; Chi CS
    Acta Paediatr Taiwan; 2001; 42(4):248-51. PubMed ID: 11550416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.